Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05240885 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metabolic and Functional Consequences of Aging in Health and Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Sep 2026 → Sep 2028
See other at-risk trials from Texas A&M University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 2026 to Sep 2028 Show 4 more changesShow less
    • Lead sponsor: Texas A&M University to Texas A&M University
    • Eligibility criteria expanded, about 51 words
    • Secondary endpoints: details revised at 6 of 19 entries
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Feb 2025 to Sep 2026
    • Study completion date: Dec 2025 to Sep 2026
    • Start date changed from estimate of Mar 2022 to Mar 4, 2022
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Current knowledge of the aging experience and the trajectories of physical and cognitive decline across various age groups are not well-understood, yet crucial to prevent spending added years in disease. Hence, the study objective is to develop the metabolic profile associated with aging-related disorders measured as the incidence of impaired functional capacity, cognitive function, and/or well-being.
Trial Details
NCT Number NCT05240885
Lead Sponsor Texas A&M University
Conditions
(from sponsor)		 Aging
Related terms Disease
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov